HOLLAND, Mich., July 10, 2018—Genesis Innovation Group’s cultivate(MD) Capital Fund II, LP, a fund focused on investments in early stage healthcare companies with innovative technologies, announces its investment into SafKan …
Holland-based Genesis Innovation Group LLC raised $7.2 million of its $10 million goal toward a fund to invest in early stage health care companies, particularly those developing medical devices and …
The organizers behind the new cultivate(MD) Capital Fund GP LLC found backers by appealing to their own global professional networks and investors with whom they had previously done business. Many …
A Holland-based venture capital firm closed last week on $7.2 million of the $10 million it seeks to raise to invest in health care startups. Formed last fall by Genesis …
Genesis Innovation Group and cultivate (MD) Capital Funds are dedicated to bringing emerging health care innovations to market. HOLLAND, Mich., March 6, 2018 —Genesis Innovation Group, LLC, (Genesis) an emerging …
HOLLAND, Mich., December 2017 – Shoulder Innovations, an emerging developer of shoulder replacement systems, today announced it closed a $1.6 million round of Series A equity funding. Demand for the …
Wright Medical (WMGI) Acquires IMASCAP SAS for $88.8 Million Wright Medical Group N.V. today announced the acquisition of IMASCAP SAS, a leader in the development of software-based solutions for preoperative …
$10 Million Fund is dedicated to bringing emerging healthcare innovations to market. HOLLAND, Mich., November 28, 2017— Genesis Innovation Group, LLC, an emerging developer of medical device technologies, today announced …
GRAND RAPIDS, Mich., August 24, 2017—Genesis Innovation Group today announced a strategic partnership with Spectrum Health Innovations (SHI) to bring a new and innovative shoulder brace to market. This is …
Holland, MI-based Genesis Innovation Group announced early this month that it has raised $1.1 million in capital to invest in new medical device technologies. Since its 2013 inception, Genesis has …
